Delivery Order SPE2DB22D1017-SPE2DB24FF2TN
- Not listed
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,758.47, is for the delivery of NAFTIN 2% GEL 45GM medical products. It is a firm fixed-price delivery order contract with a completion date of February 7, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,153.04, is for the provision of NAFTIN 2% GEL 60GM, a prescription pharmaceutical product. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen, a for-profit organization and major supplier of pharmaceutical products and medical supplies to the federal government, is the prime contractor....
- This federal contract award, valued at $6,094.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NAFTIN 2% Gel, a pharmaceutical product, with an ultimate completion date of October 31, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,146.45 fixed-price delivery order is for the product NAFTIN 2% GEL 45GM, with a completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- This federal contract award, valued at $5,108.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4563323990 - NAFTIN 1% GEL 40GM, a pharmaceutical product. The award has an ultimate completion date of January 16, 2024 and a firm fixed-price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,304.50 firm-fixed-price delivery order is for the provision of NAFTIN 1% GEL 60GM, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2023. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,477.36, is for the delivery of 4560955312 NAFTIN 1% GEL 40GM, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $8,908.42, is a firm fixed price delivery order for the supply of NAFTIN 1% GEL 40GM, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,248.88 firm fixed-price delivery order is for the supply of NAFTIN 1% GEL 60GM, a pharmaceutical product. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award, valued at $1,080.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAFTIN 1% GEL 60GM, a medical product, to support federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF2TNDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,622.52, is for the delivery of NAFTIN 2% GEL 60GM, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with a completion date of February 13, 2024. The contract has no set-aside designation, indicating it was awarded through open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, that serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award is likely part of that larger IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 2/12/24 |